Jed Dorsheimer, William Blair group head of energy and power technologies, joins 'Money Movers' to discuss Meta's nuclear ...

Proficient Auto Logistics, Inc. (Nasdaq: PAL) (the “Company”) today announced that Rick O’Dell, Chairman and Chief Executive ...

Markets have been anticipating hard data ‘catching down’ to soft data for some time but the 90-day pause in the imposition of ...

In-N-Out’s playbook has always held an air of mystery. Partly because the brand keeps operating principles close to the vest, ...

Fintel reports that on June 6, 2025, William Blair initiated coverage of Allstate Corporation - Preferred Stock (NYSE:ALL.PRH ...

NewAmsterdam shared new Phase 3 data showing obicetrapib reduced LDL-C by 33% and impacted Alzheimer's biomarkers ahead of ...

The FDA rejected Axsome's AXS-14 fibromyalgia, prompting a new trial and pushing the expected drug launch to 2028.

Genrix’s velinotamig complements Cullinan’s own pipeline, according to William Blair, which added that the deal will put ...

Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, today announced that Tod Carpenter, chairman, president, and chief executive officer ...

Property & casualty insurer, reinsurer, and brokerage stocks slipped in Monday trading after management commentary from Ryan ...

LPL has closed 56 deals in its succession program, using $690 million of capital, according to William Blair analyst Jeff ...

A "sub-study" of a late-stage clinical trial found the drug, obicetrapib, significantly reduced levels of a certain type of ...